Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STANDARD BIOTOOLS INC. Director's Dealing 2020

Dec 17, 2020

32853_dirs_2020-12-17_be2653dc-760f-4a0a-901f-ab2349c02b61.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FLUIDIGM CORP (FLDM)
CIK: 0001162194
Period of Report: 2020-12-15

Reporting Person: Stankovic Ana K. (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-12-15 Common Stock A 8221 Acquired 8221 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-12-15 Stock Option (Right to Buy) $6.69 A 12237 Acquired 2030-12-15 Common Stock (12237.0) Direct

Footnotes

F1: Represents Restricted Stock Units that vest in four equal annual increments beginning December 15, 2021.

F2: The Option becomes exercisable in four equal annual increments beginning on December 15, 2021.